...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>藥學雜誌 >An examination in comparison web site with other root on the revised information of drug package insert.
【24h】

An examination in comparison web site with other root on the revised information of drug package insert.

机译：在比较网站上与其他根目录一起检​​查药品包装说明书的修订信息。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To obtain revised information on drug package inserts, we evaluated the quality and comprehensibility of such information provided by the Web site of the Pharmaceuticals and Medical Devices Agency (PMDA site), medical representatives (MRS), Drug Safety Updates (DSUS), and informational publications of the wholesale distributor Company F (wholesaler F). In the comparison of the total amount of revised information obtained from April 2003 to March 2004, the PMDA site was 90% or greater of comprehensible. In comparison with the distribution information on the notice of the Ministry of Health, Labor and Welfare, an informational delay or lack occasionally occurred and variations among pharmaceutical companies were observed. Moreover, on the PMDA site, the number of revisions was 1972. Among them, clinically important information, such as warnings, contraindications, adverse effects, and drug interactions, totaled 37%. From these results, it is suggested that there are variations in the information from each pharmaceutical company on the PMDA site although the site is excellent in terms of comprehensibility.
机译：为了获得有关药品包装说明书的修订信息，我们评估了由药品和医疗器械局（PMDA网站），医疗代表（MRS），药品安全更新（DSUS）和信息性网站提供的此类信息的质量和可理解性批发发行商F公司（批发商F）的出版物。从2003年4月至2004年3月获得的修订信息总量进行比较，PMDA网站占可理解的90％或更高。与厚生劳动省公告的分发信息相比，偶尔会出现信息延迟或缺乏，并且观察到制药公司之间的差异。此外，在PMDA网站上，修订次数为1972年。其中，临床上重要的信息，例如警告，禁忌症，不良反应和药物相互作用，总计占37％。从这些结果可以看出，尽管该站点在可理解性方面非常出色，但每个制药公司在PMDA网站上提供的信息都有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号